Blood bank reagents

Ended Awarded Last action

Contract number
36C24923F0018
Awardee
Awarding agency
Obligated
$151,955

Award facts

Contract value 47% obligated
  • $151,954.65 Current, with exercised options
  • $321,029.85 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Sparks Glencoe, MD 21152, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00008 · OY 3 blood culture decrease excess funds from FY 25 PO -$37,106
Exercise an Option P00007 · OY 3 blood culture $56,358
Funding Only Action P00006 · OY3 decrease excess funds -$36,373
Funding Only Action P00005 · Fund blood bank reagents option year 2 renewal $56,358
Exercise an Option P00004 · Blood bank reagents option year 2 renewal $0
Funding Only Action P00003 $56,358
Exercise an Option P00002 · Blood bank reagents option year 1 renewal $0
Other Administrative Action P00001 · Add options clauses $0
Original award $56,358

About this award

Becton, Dickinson and Company (BD), through its Infectious Disease Systems (IDS) division, was awarded a delivery order valued at $321,029.85 for blood bank reagents by the Department of Veterans Affairs, Veterans Integrated Service Network 9. This firm fixed-price contract, with an ultimate completion date of September 30, 2026, represents a reduction in excess funds from the fiscal year 2025 purchase order and was awarded without a set-aside designation. The work will be performed at BD's facility in Sparks Glencoe, Maryland. This delivery order falls under BD's larger Federal Supply Schedule contract (FSS-66-III, Critical Analyzers, Laboratory) and leverages the company's established capability as a leading supplier of diagnostic and laboratory solutions to VA facilities.

The delivery order supports the VA's ongoing need for critical blood bank reagents and supplies to support diagnostic and clinical operations across its healthcare system. BD's IDS division specializes in providing comprehensive blood culture systems, microbiology analyzers, and related diagnostic reagents to federal healthcare facilities. As a global medical technology company with extensive federal contracting experience across multiple agencies including the VA, Department of Defense, and National Institutes of Health, BD demonstrated competitive capability to fulfill this requirement on a full and open competition basis.

Quick answers

Who was awarded contract 36C24923F0018?

36C24923F0018 was awarded to Becton, Dickinson And Company by Veterans Integrated Service Network 9 (Veterans Health Administration) on October 1, 2022.

How much is contract 36C24923F0018 worth?

The government has obligated $151,955 on 36C24923F0018. Its current value, with exercised options, is $151,955. Its potential value, with all options, is $321,030.

Is contract 36C24923F0018 an order under another contract?

Yes. 36C24923F0018 is a delivery order under V797D40095, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).

Was contract 36C24923F0018 competed?

The extent of competition for 36C24923F0018 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award